Apremilast-d5
Apremilast-d5 is a deuterium labeled Apremilast. Apremilast is an orally available inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with an IC50 of 74 nM. Apremilast inhibits TNF-α release by lipopolysaccharide (LPS) with an IC50 of 104 nM[1].
Product Specifications
CAS Number
[1258597-47-5]
Product Name Alternative
CC-10004-d5
UNSPSC
12352005
Hazard Statement
H302+H312+H332, H315, H319
Target
Apoptosis; Phosphodiesterase (PDE) ; TNF Receptor
Type
Isotope-Labeled Compounds
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
99.26
Solubility
DMSO : 44mg/mL (ultrasonic)
Smiles
CC(NC1=CC=CC(C(N2[C@@H](C3=CC=C(OC)C(OC([2H])([2H])C([2H])([2H])[2H])=C3)CS(=O)(C)=O)=O)=C1C2=O)=O
Molecular Formula
C22H19D5N2O7S
Molecular Weight
465.53
Precautions
H302+H312+H332, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
PDE4; TNFRSF5/CD40
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
